Skip to content

Ugandan Researchers’ Mission to Build Africa’s Testing Capability

Uganda on Wednesday launched a rapid COVID-19 antibody test partly funded by France that developers hope to market in sub-Saharan Africa, where the laboratory infrastructure needed for extensive novel coronavirus testing is thin. The test, which requires a finger prick to draw blood, was developed by a team at Makerere, Uganda’s oldest public university, with partial funding from the French embassy. The east African country has long experience of infectious diseases like HIV and Ebola which it has drawn on to develop diagnostics expertise. “This is a point-of-care test that can be used within equatorial Africa village settings, remote areas where there’s no laboratory, there’s no electricity, there’s no expert,” said Misaki Wayengera, a researcher at Makerere’s Department of Pathology. The kits work by detecting two antibodies, immunoglobulin M (IgM) and immunoglobulin G (IgG), triggered when someone is infected with coronavirus, Wayengera told Reuters before the launch at Mulago, Uganda’s national referral hospital. Makerere partnered with local firm Astel Diagnostics Uganda, a World Health Organisation-certified manufacturer, to make an initial batch of 2,400 tests. Wayengera said they are in talks with bigger investors about larger commercial production.